Clinical trial
T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow…
NCT00048464 · Xcyte Therapies, Industry · Unknown status
Key facts
| NCT number | NCT00048464 |
|---|---|
| Title | T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant |
| Official title | A Phase I/II Study of Xcellerated T Cells After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma |
| Lead sponsor | Xcyte Therapies, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Procedure |
| Interventions | Infusion of Activated & Expanded Autologous T Cells |
| Enrollment | 35 |
| Start date | Oct 1, 2002 |
| First posted | Nov 4, 2002 |
| Last update posted | Nov 7, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: